Title: Trump’s Executive Order: A Step Towards Medical Marijuana Legalization? In an unexpected move, President Donald Trump signed an executive order to fast-track the reclassification of cannabis on Thursday. This decision paves the way for the Food and Drug Administration (FDA) to study its medicinal uses, potentially opening up new avenues in medical research and treatment options. The president clarified that this action does not legalize marijuana nationwide nor sanction its use as a recreational drug but aims at helping people struggling with chronic pain. Cannabis is currently classified under the same category as heroin, ecstasy, and LSD in the Controlled Substances Act of 1970. Trump’s order directs it to be reclassified a Schedule III substance, defined by the Drug Enforcement Administration (DEA) as “drugs with a moderate to low potential for physical and psychological dependence.” Other examples of Schedule III drugs are Tylenol with codeine, ketamine, and testosterone. The executive order directs Attorney General Pam Bondi to conclude the formal rescheduling process that has been ongoing for over a year and move towards publishing a final rule that would reclassify cannabis. Changing its classification to Schedule III will ease regulatory hurdles and allow the FDA to study medical applications of marijuana, potentially leading to wider medical use by seniors, veterans, and others as a pharmaceutical product irrespective of state laws. The goal of this order is “to remove barriers to research” and “start working to improve the medical marijuana and CBD research to better inform patients and doctors,” according to a senior administration official who spoke before the signing. This decision could have significant implications on how we approach cannabis as both medicine and recreation in the future, especially considering its potential benefits for those suffering from chronic pain or other debilitating conditions. While this move does not legalize marijuana nationwide nor endorse its use as a recreational drug, it represents an important step towards acknowledging the medicinal value of cannabis. It remains to be seen how this decision will impact public opinion and future legislation surrounding marijuana usage in America. However, one thing is clear – President Trump’s executive order marks a significant shift in attitude towards medical marijuana use within the United States government.
Source: [Original Article](https://www.nbcnews.com/politics/trump-administration/trump-signs-executive-order-fast-tracking-reclassification-marijuana-rcna249741)
#trump
Check out my AI projects on Hugging Face, join our community on Discord, and explore my services at GhostAI!
